Neurodegeneration Across Mechanisms, Epidemiology, and Emerging Therapies: Inflammation, Metabolism, Aging, and Neuromodulation

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".

Deadline for manuscript submissions: 30 June 2026 | Viewed by 6

Special Issue Editor


E-Mail Website
Guest Editor
Department of Medicine, Complutense University, Madrid, Spain
Interests: neurology; neurodegenerative; epidemiology

Special Issue Information

Dear Colleagues,

Neurodegenerative diseases impose a growing global burden, driven by the convergence of neuroinflammation, metabolic dysfunction, and aging-related processes that collectively accelerate neuronal vulnerability and loss. Mechanistic advances—from microglial and astroglial signaling to mitochondrial and proteostasis failure—are increasingly complemented by epidemiological insights that map incidence, risk, and population-level heterogeneity across diverse cohorts. Bridging these levels of analysis is essential to identify modifiable targets and to translate biology into preventive and disease-modifying interventions.

This Special Issue invites studies that integrate mechanistic, epidemiological, and therapeutic perspectives on neurodegeneration. We welcome preclinical and clinical work on: (i) immune and glial pathways (e.g., NLRP3, complement, TREM2) and their modulation; (ii) metabolic and mitochondrial targets (e.g., insulin/GLP‑1 signaling, lipidomics, mitophagy); (iii) aging biology (e.g., inflammaging, senescence, proteostasis); (iv) biomarkers for risk stratification, target engagement, and patient selection; and (v) emerging treatments, including pharmacologic approaches (immunomodulators, metabolic modulators, anti‑aggregation/anti‑tau/synuclein strategies), non‑pharmacological interventions (exercise, nutrition, digital therapeutics), and noninvasive brain stimulation such as repetitive transcranial magnetic stimulation (rTMS) and theta‑burst stimulation (TBS)—i.e., estimulación magnética transcraneal—as well as other neuromodulatory paradigms under investigation. Methodological contributions on trial design, real-world evidence, causal inference, and population-based risk modeling are encouraged. By connecting biology, population science, and therapeutic innovation, this Special Issue aims to accelerate translational pipelines and inform rational strategies for prevention and treatment across the neurodegenerative spectrum.

Dr. Julian Benito Leon
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neurodegeneration
  • neuroinflammation
  • metabolic dysfunction
  • aging and inflammaging
  • epidemiology
  • biomarkers
  • neuromodulation
  • transcranial magnetic stimulation (TMS)

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop